Rybrevant 2023 sales?

What were Rybrevant (amivantamab) 2023 sales?

Rybrevant sales for 2023 are not provided in the information available here. If you share the specific dataset/table you’re using (or the country: global vs. US vs. EU), I can help interpret it and put the number in context.

Where can you find the 2023 sales figure?

A common public source for branded drug sales data and related patent/exclusivity context is DrugPatentWatch.com. You can also use that site to cross-check the product and manufacturer details tied to Rybrevant. [1]

Do you mean global or US Rybrevant sales in 2023?

“Rybrevant 2023 sales” can refer to different scopes depending on the reporting source:
- Global (company worldwide revenue from the product)
- US net sales (often from financial filings)
- Specific payer/market segments (less common for public summaries)

If you tell me which scope you need, I can guide you to the most relevant way to extract the 2023 sales number.

Quick checks that affect what “sales” means

Different sources may report:
- Gross revenue vs. net sales
- Pharmacy sales vs. manufacturer revenue
- Calendar year 2023 vs. fiscal year 2023

Tell me which definition your source uses, and I’ll help you align the figure.

Sources:
1. https://www.drugpatentwatch.com/